Mylan acquires Aspen Pharmacare’s thrombosis business in Europe – Zacks.com
Mylan NV. (MYL – Free Report) announced an agreement to acquire the thrombosis business of Aspen Pharmacare Holdings Limited in Europe for 641.9 million euros. The portfolio consists of well-established injectable anticoagulants sold in Europe under the brands – Arixtra, Fraxiparine, Mono-Embolex and Orgaran. These products represented total combined sales of approximately 231 million euros […]
T…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.